Jazz Pharma EVP Global Head of R&D and CMO Robert Iannone disposes of shares worth $19.23 million

Reuters2026/08/31 22:46

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Robert Iannone, EVP, Global Head of R&D & CMO at Jazz Pharmaceuticals, reported stock option exercises and share sales on Aug. 27.
Disposed of 76,921 ordinary shares at weighted average prices from USD 247.86 to USD 252.76.
Exercised options for 57,500 ordinary shares at USD 113.1 and USD 137.12.
Beneficial ownership stood at 65,686 ordinary shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001737329-26-000016), on August 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Jazz Pharma EVP Global Head of R&D and CMO Robert Iannone disposes of shares worth $19.23 million

You may also like

Crypto prices